Sort
30,917 grants matching “tumor microenvironment”
Contemporary Approaches to Cancer Cell Signaling and Communication
$635,208Jing Yang · University Of California, San Diego · T32 · FY2024 · CA
A model for predicting response to PD-1 inhibitors in NSCLC
$635,207Edward B Garon · University Of California Los Angeles · R01 · FY2021 · CA
A model for predicting response to PD-1 inhibitors in NSCLC
$635,187Edward B Garon · University Of California Los Angeles · R01 · FY2020 · CA
Mechanisms of lmmunosuppression in MYCN-driven Neuroblastoma
$635,173Hui Feng · Boston University Medical Campus · R01 · FY2025 · NS
Non-canonical Wnt-Receptor Signaling and Targeted Therapies
$635,146Thomas J. Kipps · University Of California, San Diego · R01 · FY2019 · CA
Modulation of Therapeutic Response
$635,139James B Mitchell · Clinical Sciences · Z01 · FY2007 · CA
Dynamic Imaging of EMT in the Breast Cancer Microenvironment
$635,130Olav Solgaard · Stanford University · R01 · FY2016 · CA
Contribution of Myeloid-Derived Suppressor Cells to Neuro-Inflammatory Alterations and Disease Progression in Glioblastoma
$635,095Justin D. Lathia · Cleveland Clinic Lerner Com-Cwru · R35 · FY2024 · NS
IL-15 and -21 armored GPC3-specific CAR T cells for children with solid tumors
$635,004Andras A. Heczey · Baylor College Of Medicine · R01 · FY2022 · CA
Stomal Senescence Regulator of Tumor Immunity and Progression
$634,970David G Denardo · Washington University · R01 · FY2025 · CA
A phase I/II study of combined therapy with Th17-inducing dendritic cells and pembrolizumab in patients with recurrent epithelial ovarian cancer
$634,953Keith L Knutson · Mayo Clinic Jacksonville · R01 · FY2023 · CA
Targeting Non-Canonical STING Signaling to Treat SPOP Mutant Castration-Resistant Prostate Cancer
$634,907Timothy C Thompson · University Of Tx Md Anderson Can Ctr · R01 · FY2024 · CA
Novel Determinants for Progression of Non-Alcoholic Fatty Liver Disease to Hepatocellular Carcinoma and Other Health Outcomes
$634,830Jian-Min Yuan · University Of Pittsburgh At Pittsburgh · R01 · FY2021 · CA
Disrupting the Prostate Tumor Microenvironment in African American Men to Promote Response to Immuno-Modulatory Therapy
$634,819Kosj Yamoah · H. Lee Moffitt Cancer Ctr & Res Inst · R37 · FY2024 · CA
Dissecting the Kaposi Sarcoma Tumor Microenvironment at the Single Cell Level
$634,763Warren Phipps · Fred Hutchinson Cancer Center · R01 · FY2022 · CA
Detection, Radiosensitization and Theranostic Targeting of Metastatic Breast Cancer by PTPmu
$634,738Susann M Brady-Kalnay · Case Western Reserve University · R01 · FY2024 · CA
CPMV-Polymer Devices to Enhance the Outcomes of Intratumoral Immunotherapy
$634,736Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2025 · CA
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$634,693Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2020 · CA
Tailoring CAR T cell therapy for Hodgkin Lymphoma
$634,693Barbara Savoldo · Univ Of North Carolina Chapel Hill · R01 · FY2021 · CA
Clinically Translatable Ultrasound-Sensitive Microbubble Approaches for Overcoming Tumor Hypoxia
$634,686John Eisenbrey · Thomas Jefferson University · R01 · FY2018 · EB
Role of Cancer-Associated Fibroblasts in Cholangiocarcinoma
$634,470Robert F. Schwabe · Columbia University Health Sciences · R01 · FY2018 · CA
Quantitative imaging and molecular data modeling for brain tumor recurrence and progression analysis
$634,465Khan M Iftekharuddin · Old Dominion University · R01 · FY2025 · EB
Targeting KRAS and adenosine mediated immunosuppression in pancreatic cancer
$634,454Caius Gabriel Radu · University Of California Los Angeles · R01 · FY2021 · CA
Propionate metabolism and cancer
$634,435John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2025 · CA
Propionate metabolism and cancer
$634,435John Blenis · Weill Medical Coll Of Cornell Univ · R01 · FY2023 · CA